|
POL 2022
COI 11.25 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/mut (carrier)
-
25/9/2024
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
25/9/2024
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
17/10/2023
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
6/10/2023
|
|
FIN 2012
COI 2.70 %
*
Breed relevant health information:
Hips
Fair / B1 / 4-6 / B / 11-18
-
15/3/2013
|
|
|||
FIN 2014
COI 3.31 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
clear by parentage
Progressive retinal atrophy (prcd-PRA)
clear by parentage
|
|
||
FIN 2009
COI 2.55 %
*
Breed relevant health information:
Hips
Mild / C1 / 9-12 / C / 26-35
-
31/8/2010
|
|||
POL 2021
COI 2.15 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/mut (carrier)
-
25/9/2024
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
25/9/2024
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
17/10/2023
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
6/10/2023
|
|
|
|
|
|||
HUN 2019
COI 3.84 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
FIN 2014
COI 3.09 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
||
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Ukumi Magia Syberii
|
6 Dec 2021 | N/mut (carrier) | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | |||||
Degenerative myelopathy (DM):
N/mut (carrier)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Uuno Suopunki Albus
|
7 Mar 2022 | N/mut (carrier) | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | |||||
Degenerative myelopathy (DM):
N/mut (carrier)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Siblings | ||||||||||
Barfi Šungmánitu-ha Khoyáke
|
7 Mar 2025 | |||||||||
Borga Šungmánitu-ha Khoyáke
|
7 Mar 2025 | |||||||||
Buoremus Šungmánitu-ha Khoyáke
|
7 Mar 2025 | |||||||||
Búri Šungmánitu-ha Khoyáke
|
7 Mar 2025 | |||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
Aava Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Abba Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Ahti Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Aili Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Alvar Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Annukka Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Arja Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Aroha Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Aslak Šungmánitu-ha Khoyáke
|
6 Sep 2024 | |||||||||
Offspring |